Imperial College London
Portrait Picture

ProfessorMarcGunter

Faculty of Medicine, School of Public Health

Chair in Cancer Epidemiology
 
 
 
//

Contact

 

+44 (0)20 7594 2623m.gunter

 
 
//

Location

 

VC2Medical SchoolSt Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Ose:2015:10.1038/bjc.2014.566,
author = {Ose, J and Fortner, RT and Schock, H and Peeters, PH and Onland-Moret, NC and Bueno-de-Mesquita, HB and Weiderpass, E and Gram, IT and Overvad, K and Tjonneland, A and Dossus, L and Fournier, A and Baglietto, L and Trichopoulou, A and Benetou, V and Trichopoulos, D and Boeing, H and Masala, G and Krogh, V and Matiello, A and Tumino, R and Popovic, M and Obon-Santacana, M and Larranaga, N and Ardanaz, E and Sanchez, M-J and Menendez, V and Chirlaque, M-D and Travis, RC and Khaw, K-T and Braendstedt, J and Idahl, A and Lundin, E and Rinaldi, S and Kuhn, E and Romieu, I and Gunter, MJ and Merritt, MA and Riboli, E and Kaaks, R},
doi = {10.1038/bjc.2014.566},
journal = {British Journal of Cancer},
pages = {162--166},
title = {Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort},
url = {http://dx.doi.org/10.1038/bjc.2014.566},
volume = {112},
year = {2015}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Background: Prospective studies on insulin-like growth factor I (IGF-I) and epithelial ovarian cancer (EOC) risk are inconclusive.Data suggest risk associations vary by tumour characteristics.Methods: We conducted a nested case–control study in the European Prospective Investigation into Cancer and Nutrition (EPIC)to evaluate IGF-I concentrations and EOC risk by tumour characteristics (n ¼ 565 cases). Multivariable conditional logisticregression models were used to estimate associations.Results: We observed no association between IGF-I and EOC overall or by tumour characteristics.Conclusions: In the largest prospective study to date was no association between IGF-I and EOC risk. Pre-diagnostic serumIGF-I concentrations may not influence EOC risk.
AU  - Ose,J
AU  - Fortner,RT
AU  - Schock,H
AU  - Peeters,PH
AU  - Onland-Moret,NC
AU  - Bueno-de-Mesquita,HB
AU  - Weiderpass,E
AU  - Gram,IT
AU  - Overvad,K
AU  - Tjonneland,A
AU  - Dossus,L
AU  - Fournier,A
AU  - Baglietto,L
AU  - Trichopoulou,A
AU  - Benetou,V
AU  - Trichopoulos,D
AU  - Boeing,H
AU  - Masala,G
AU  - Krogh,V
AU  - Matiello,A
AU  - Tumino,R
AU  - Popovic,M
AU  - Obon-Santacana,M
AU  - Larranaga,N
AU  - Ardanaz,E
AU  - Sanchez,M-J
AU  - Menendez,V
AU  - Chirlaque,M-D
AU  - Travis,RC
AU  - Khaw,K-T
AU  - Braendstedt,J
AU  - Idahl,A
AU  - Lundin,E
AU  - Rinaldi,S
AU  - Kuhn,E
AU  - Romieu,I
AU  - Gunter,MJ
AU  - Merritt,MA
AU  - Riboli,E
AU  - Kaaks,R
DO  - 10.1038/bjc.2014.566
EP  - 166
PY  - 2015///
SN  - 1532-1827
SP  - 162
TI  - Insulin-like growth factor I and risk of epithelial invasive ovarian cancer by tumour characteristics: results from the EPIC cohort
T2  - British Journal of Cancer
UR  - http://dx.doi.org/10.1038/bjc.2014.566
UR  - http://hdl.handle.net/10044/1/29143
VL  - 112
ER  -
Download